Mark Elliott Boulding serves as Executive at PTC THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Mark Elliott Boulding has executed 166 insider transactions totaling $26.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 28, 2019 involved selling 44,090 shares valued at $2.0M.
Mark Elliott Boulding currently holds 106,713 shares of PTC THERAPEUTICS, INC. (PTCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Elliott Boulding has been a net seller of PTCT stock. They have purchased $0 and sold $26.0M worth of shares.
Mark Elliott Boulding's most recent insider trade was on Jun 28, 2019, when they sold 44,090 shares at $45.00 per share.
Get notified when new Form 4 filings are submitted
| $27.05 |
| Discretionary |
| Jun 28, 2019 | PTCT | $51.3K | Sale | 1,140 | $45.00 | Discretionary |
| Jun 28, 2019 | PTCT | $12.8K | Option Exercise | 1,140 | $11.23 | Discretionary |
| Jun 28, 2019 | PTCT | $83.0K | Sale | 1,844 | $45.00 | Discretionary |
| Jan 3, 2017 | PTCT | $0 | Award | 9,000 | $N/A | Discretionary |
| Jun 8, 2015 | PTCT | $542.5K | Option Exercise | 50,000 | $10.85 | Discretionary |
| Jun 8, 2015 | PTCT | $131.1K | Option Exercise | 12,083 | $10.85 | Discretionary |
| Jun 8, 2015 | PTCT | $177.2K | Sale | 3,140 | $56.42 | Discretionary |
| Jun 8, 2015 | PTCT | $1.4M | Sale | 24,609 | $55.62 | Discretionary |
| Jun 8, 2015 | PTCT | $1.0M | Sale | 18,324 | $54.70 | Discretionary |
| Jun 8, 2015 | PTCT | $580.5K | Sale | 10,776 | $53.87 | Discretionary |
| Mar 20, 2015 | PTCT | $518.6K | Sale | 7,547 | $68.72 | Discretionary |
| Mar 20, 2015 | PTCT | $911.7K | Sale | 13,453 | $67.77 | Discretionary |
| Mar 20, 2015 | PTCT | $9.9K | Sale | 142 | $69.77 | Discretionary |
| Mar 20, 2014 | PTCT | $311.1K | Sale | 10,049 | $30.96 | Discretionary |